Endo International Profile

16.12
USD 0.17  1.04%
41%
11%

Exercise of in-the-money or at-the-money derivative position by Kelso Investment Assoc V L P of 15203 shares of Endo International

Endo International plc insider trading alert for exercise of call option (obligation to sell) by Kelso Investment Assoc V L P, the corporate stakeholder, on September 24, 2018. This event was filed by Endo International Plc with SEC on 2005-11-03. Statement of changes in beneficial ownership - SEC Form 4 [view details]   

Endo International Summary

Endo International plc (ENDP) is traded on BATS Exchange in USA. It is located in IRELAND and employs 3,039 people. Endo International is listed under Pharmaceutical Products category by Fama And French industry classification.The company currently falls under 'Mid-Cap' category with current market capitalization of 3.61 B. Endo International plc conducts business under Healthcare sector and is part of Drug Manufacturers - Specialty & Generic industry. This company has 223.93 M outstanding shares of which 37.15 M shares are currently shorted by private and institutional investors with about 6.36 trading days to cover. ENDO PHARM HLDGS currently holds about 1.1 B in cash with 434.03 M of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 4.91.
Check Endo International Probability Of Bankruptcy

Ownership Allocation (%)

Endo International Target Price Odds Analysis

Odds Below 16.12HorizonTargetOdds Above 16.12
35.11%30 days 16.12 64.56%
Based on normal probability distribution, the odds of Endo International to move above current price in 30 days from now is about 64.56% (This Endo International plc probability density function shows the probability of Endo International Stock to fall within a particular range of prices over 30 days) .

Endo International plc Top Holders

Endo International Major Institutional Holders

InstituionSecurity TypeTotal SharesValue
Blackrock IncCommon Shares32.3 M304.9 M
Glenview Capital Management LlcCommon Shares22.3 M210.2 M
View Endo International Diagnostics

Endo International plc Income Statement Over Time

Consolidated Income    Earning Before Interest and Taxes EBIT    Net Income    

Endo International Key Fundamentals

Endo International Against Markets

Endo International Current Ratings

Endo International plc 30 Days Performance Scores

Risk Adjusted
Performance Score (0 to 100)
2 
Chance of
Financial Distress (0 to 100%)
51 
Equity ratings for Endo International plc are calculated dynamically based on Macroaxis scoring framework. Click here to learn more
Endo International plc, a specialty pharmaceutical company, manufactures and sells generic and branded pharmaceuticals in the United States, Canada, and internationally. Endo International plc was founded in 1920 and is headquartered in Dublin, Ireland. Endo International operates under Drug Manufacturers - Specialty Generic classification in USA and traded on BATS Exchange. It employs 30 people. more
Fama & French Pharmaceutical Products
Pharmaceutical Products
Fama & French Classification
Endo International plc SEC Filings
Endo International SEC Filings
Security & Exchange Commission EDGAR ReportsView All
NameEndo International plc
Special Advisor to the CEODonald DeGolyerView All
Thematic Classifications
Active Investing Ideas
showing 2 out of 3 themes  View All
Analyst Consensus
Piotroski F Score
Macroaxis Advice
Bond Rating
Specialization
Healthcare, Drug Manufacturers - Specialty & Generic
InstrumentUSA Stock View All
LocationIRELAND
Business AddressMinerva House
ExchangeBATS Exchange
ISINUS29264F2056
CUSIPSBJ3V9056
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
BenchmarkDOW
Websitewww.endo.com
Phone353 1 268 2000
CurrencyUSD - US Dollar
Next Fiscal Year EndDecember 31, 2019
Most Recent QuarterJune 30, 2018
Last Fiscal Year EndDecember 31, 2017
Date Short InterestAugust 31, 2018

Endo International Directors

Endo International Corporate Directors

William Spengler Director
Arthur Higgins Independent Director
William Montague Director
Additionally see Investing Opportunities. Please also try Correlation Analysis module to reduce portfolio risk simply by holding instruments which are not perfectly correlated.
Search macroaxis.com